fbpx
Saturday, January 16, 2021
$82 billion pharma huge Bristol-Myers Squibb simply suffered a significant obstacle in its hunt for a lung-cancer treatment, however the drugmaker isn’t retreating from its questionable technique (BMY)

$82 billion pharma huge Bristol-Myers Squibb simply suffered a significant obstacle...

0
Lung cancer is the most deadly kind of cancer in the US, and it's a crucial market for drugmakers that hope to offer better treatments for the disease. One of those drugmakers is Bristol-Myers Squibb, which has been trying to prove that a combination of two of its existing cancer drugs will help patients with…
Pharma huge GSK simply made a $5.1 billion bet on a cancer drugmaker (GSK, TSRO)

Pharma huge GSK simply made a $5.1 billion bet on a...

0
GlaxoSmithKline is getting deeper into cancer drug development. On Monday, the UK-based pharma giant said it had agreed to acquire Tesaro, a cancer drugmaker with a treatment for ovarian cancer, for $5.1 billion. Tesaro was up 60% on the news before markets opened Monday while GSK was down 6%. GSK has been working to refresh…

Recent Posts